QIAGEN OmicSoft and Biomedical Knowledge Base

Checkpoint inhibitors in the context of biomarkers, drug targets and pathways

May 11, 2023
In this training, we will focus on how you can use QIAGEN Omicsoft Studio and QIAGEN Ingenuity Pathway Analysis (IPA) to discover new biomarkers, validate (or study) drug targets and identify novel mechanisms of action with your own and/or public checkpoint inhibitor datasets from resources like GEO, SRA, TCGA and more.

In this training, you’ll learn how to:

· Investigate the expression of a gene/biomarker/drug target across different treatments and diseases

· Derive a biomarker/gene signature from a specific condition (for example, non-responders of a drug, or a particular disease/disease subtype and others)

· Correlate expression of multiple genes and biomarkers

· Compare different experimental groups (e.g., your own data and/or public data) at both the levels of gene expression and pathways/regulatory networks activity

Related videos

QIAGEN OmicSoft and Biomedical Knowledge Base

Biomarker discovery, target validation, and variant identification using QIAGEN OmicSoft...

87 views March 04, 2024

In this webinar, users will learn how to leverage solutions from QIAGEN...

QIAGEN OmicSoft and Biomedical Knowledge Base

Drug treatment, toxicology and target safety assessment using QIAGEN IPA and OmicSoft

137 views September 06, 2023

In this 90-minute training, you'll learn how to perform drug treatment,...

QIAGEN OmicSoft and Biomedical Knowledge Base

Integrating deeply curated omics data with APIs for biomarkers and drug target investigation

37 views April 15, 2024

This webinar is for data scientists and bioinformaticians who need extensive...

QIAGEN OmicSoft and Biomedical Knowledge Base

Target exploration and cell line selection for drug discovery

125 views December 18, 2023

Cancer cell line models have been a cornerstone of cancer research for...